Genmab Q3 Profit Falls as Revenue Rises; FY26 Outlook Maintained
Genmab reported net profit of $342 million, or $5.581 per share, versus $401 million, or $6.46 per share a year earlier. Revenue increased to $1.187 billion from $1.022 billion, and the company maintained its FY26 revenue outlook.
BRUSSELS (dpa-AFX) - Thursday, Genmab A/S (GMAB) announced its financial results for the third quarter, reporting a net profit of $342 million, or $5.581 a share, compared with $401 million, or $6.46 a share, in the previous year.Revenue increased to $1.187 billion from last year's $1.022 billion.F…